Newswires

US Enforcement Actions Highlight Risks from Online Counterfeit Pharmaceuticals, New Analysis Finds

LISBON – Recent enforcement actions by U.S. authorities are drawing renewed attention to the risks posed by online sales of counterfeit pharmaceuticals, particularly those involving synthetic opioids such as fentanyl, according to a new analysis of publicly available government data and court filings. In February 2026, the U.S. Drug Enforcement Administration (DEA), working with international […]

US Enforcement Actions Highlight Risks from Online Counterfeit Pharmaceuticals, New Analysis Finds Read More »

Inside India’s Hidden Chemical Pipeline: How Pharmaceutical Firms Fuel America’s Fentanyl Flow

For years, U.S. authorities have tracked the flow of illicit synthetic opioids into the country via complex global supply chains. The Drug Enforcement Administration (DEA) and U.S. Customs and Border Protection (CBP) have repeatedly flagged shipments containing Fentanyl and its precursor chemicals, many of which trace back to India — now among the largest exporters

Inside India’s Hidden Chemical Pipeline: How Pharmaceutical Firms Fuel America’s Fentanyl Flow Read More »